We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP.
- Authors
Bahls, Martin; Könemann, Stephanie; Markus, Marcello R. P.; Wenzel, Kristin; Friedrich, Nele; Nauck, Matthias; Völzke, Henry; Steveling, Antje; Janowitz, Deborah; Grabe, Hans-Jörgen; Felix, Stephan B.; Dörr, Marcus
- Abstract
The brain-derived neurotrophic factor (BDNF) is a neuronal growth factor essential for normal cardiac contraction and relaxation. Alterations in BDNF signaling are related to the development of cardiovascular disease. Whether BDNF is related to subclinical cardiac remodeling is unclear. We related BDNF with echocardiographic parameters and NTproBNP in a large population-based cohort (n = 2,976, median age 48 years; 45% male). Transthoracic echocardiography was performed on all subjects and BDNF was measured by ELISA. Study participants with severe kidney dysfunction, previous myocardial infarction, and LV ejection fraction <40% were excluded. Linear regression models were adjusted for age, sex, lean mass, fat mass, current smoking, systolic blood pressure and depression. Low BDNF was associated with high NTproBNP. A 10,000 pg/ml lower BDNF was related with a 2.5 g higher (95%-confidence interval [CI]: 0.2 to 4.9; p = 0.036) LV mass, 0.01 cm posterior wall thickness (0.003 to 0.022; p = 0.007) and 0.02 E/A ratio (0.003 to 0.042, p = 0.026). Here we show that low BDNF levels are related with adverse cardiac remodeling and higher levels of NTproBNP. Further research is warranted to assess if BDNF may be used to monitor neuronal-cardiac damage during CVD progression.
- Subjects
NEUROTROPHINS; CARDIAC contraction; ECHOCARDIOGRAPHY; BLOOD pressure; LEAN body mass; VENTRICULAR remodeling
- Publication
Scientific Reports, 2019, Vol 9, Issue 1, pN.PAG
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-019-51776-8